Scrotal mass screening: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Scrotal mass}} | {{Scrotal mass}} | ||
{{CMG}}{{AE}}{{SR}} | {{CMG}}{{AE}}{{NE}}{{SR}} | ||
==Overview== | ==Overview== | ||
Latest revision as of 19:28, 23 October 2019
|
Scrotal Mass Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scrotal mass screening On the Web |
|
American Roentgen Ray Society Images of Scrotal mass screening |
|
Risk calculators and risk factors for Scrotal mass screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Niloofarsadaat Eshaghhosseiny, MD[2]Sujit Routray, M.D. [3]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for testicular cancer.[1]
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for testicular cancer.[1]
References
- ↑ 1.0 1.1 Screening of testicular cancer. U.S. Preventive Service Task Force 2016. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/testicular-cancer-screening?ds=1&s=testicular%20cancer